The robotics industry is poised for unprecedented growth in 2025, driven primarily by the seamless integration of artificial intelligence technologies. This fusion is creating opportunities across multiple sectors with companies like UiPath PATH, Nvidia NVDA, Intuitive Surgical ISRG and Tesla TSLA, among others, capitalizing on the growth through innovations poised to transform everything from manufacturing floors to surgical suites.
Global advisory firm Benchmark International projects a robust 15.1% annual growth rate, with the market expected to reach $169.8 billion by 2032.
Manufacturing continues to be at the forefront of robotics adoption, with costs plummeting to make implementation more accessible than ever. Industrial robots that cost $27,000 in 2017 are projected to be available for as little as $10,856 by 2025, according to Statista analysis. This cost reduction is driving unprecedented adoption rates across global manufacturing sectors.
Healthcare represents another frontier for robotics transformation. The medical service robots market is expected to reach $84.8 billion by 2028. Breakthrough research from Johns Hopkins and Stanford demonstrates robots learning surgical procedures simply by observing and mimicking video demonstrations.
The emergence of collaborative robots (cobots) marks a significant shift in how humans and machines interact in workplaces. Market research by IDTechEx projects cobot sales volume to increase 6,100% between 2025 and 2045, with packaging and palletizing in the food and beverage industry experiencing particularly rapid growth.
In defense and space exploration, robotics is reshaping possibilities. Companies like Palantir, Anduril and AeroVironment are securing major contracts for autonomous systems development. Meanwhile, SpaceX's innovative use of robotic arms to catch reusable rockets and NASA's AI-powered Mars rovers highlight the critical role robotics plays in space exploration.
As we enter 2025, the robotics industry stands at an inflection point where rapidly advancing technology, decreasing costs, and expanding applications across diverse sectors create unprecedented investment opportunities. The fusion of AI and robotics isn't just reshaping individual industries — it's fundamentally transforming how we work, heal, and explore our world and beyond.
The Robotics Screen makes it easy to identify high-potential stocks at any given time — just like the four mentioned above. Leveraging advanced tools, the thematic screens identify companies shaping the future, making it easier to capitalize on emerging trends.
Ready to uncover more transformative thematic investment ideas? Explore 30 cutting-edge investment themes with Zacks Thematic Screens and discover your next big opportunity.
UiPath stands at the forefront of the robotics software revolution, transforming how enterprises operate through its powerful agentic automation platform. The company's strategic acquisition of Peak demonstrates its commitment to enhancing vertical AI solutions that optimize industry-specific operations.
By integrating Peak's purpose-built AI applications, UiPath now enables organizations to make highly complex decisions around inventory planning and pricing optimization with unprecedented accuracy. This acquisition perfectly positions UiPath to capitalize on the convergence of automation and agentic AI, creating specialized decision-making agents that deliver tangible business outcomes quickly. As exemplified by their success with Heidelberg Materials, UiPath's combined technologies drive revenue growth and margin improvement through intelligent, autonomous processes.
With the RPA market projected to witness a 19% CAGR over the next decade, this Zacks Rank #1 (Strong Buy) company represents a compelling investment in the future of enterprise automation. You can see the complete list of today’s Zacks #1 Rank stocks here.
NVIDIA stands at the forefront of the robotics revolution, leveraging its unparalleled AI expertise to power the next generation of intelligent machines. The company's bold venture into robotics through Project GR00T represents a watershed moment, creating a foundation model that will enable humanoid robots to understand natural language, learn from demonstrations, and perform complex tasks autonomously. This strategic initiative positions NVIDIA as the driving force behind robotics' "ChatGPT moment" that industry insiders anticipate is just around the corner.
The upcoming release of Jetson Thor in the second half of 2025 will provide robotics manufacturers with unprecedented computing power specifically designed for humanoid applications. Already empowering Tesla's Optimus bot and autonomous robotaxi service, NVIDIA's advanced chips are becoming the brain center of robotics innovation across multiple industries.
As robotics transitions from specialized industrial applications to mainstream adoption, NVIDIA's established AI leadership provides investors with exposure to this transformative technology at its very foundation. The company isn't just participating in the robotics revolution — it's providing the essential neural architecture that will define its future. NVDA currently carries a Zacks Rank #2 (Buy).
Intuitive Surgical stands as the undisputed leader in surgical robotics, positioned to transform healthcare through its revolutionary da Vinci platform. With its newest FDA-cleared iteration, the da Vinci 5, the company has elevated minimally invasive surgery to unprecedented levels through enhanced tactile feedback and advanced 3D vision systems.
This technological marvel builds upon Intuitive's impressive installed base of over 7,500 systems worldwide and more than 11 million completed procedures, creating an insurmountable competitive moat. As the global surgical robotics market expands from $12.5 billion in 2025 to a projected $45.9 billion by 2034, Intuitive's first-mover advantage and continuous innovation pipeline ensure its dominance in this high-growth sector.
This Zacks Rank #3 (Hold) company's vast repository of procedural data provides unmatched AI-learning opportunities, enabling continuous improvement in surgical outcomes and solidifying Intuitive Surgical as the premier investment vehicle to capitalize on healthcare's robotic revolution.
Tesla stands at the forefront of the robotics revolution, strategically expanding beyond electric vehicles to reshape humanity's future. This Zacks Rank #3 company's Optimus humanoid robot represents a transformative leap that could potentially eclipse Tesla's automotive business in value.
With mass production plans targeting several thousand units in 2025 and ambitious goals of 50,000-100,000 robots by 2026, Tesla is positioned to address critical global labor shortages across multiple industries. The company's robotics vision extends even further into space, with plans to send Optimus to Mars aboard SpaceX's Starship by the end of 2026, showcasing Tesla's unparalleled technological ambition and integration across Musk's companies. This Mars mission represents not just a technological milestone but a strategic competitive advantage no rival can match.
Tesla's vertical integration in AI, manufacturing expertise, and autonomous systems create a formidable foundation for leadership in the emerging $20 trillion robotics and autonomous mobility markets, offering investors exposure to perhaps the most ambitious robotics vision of any public company.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Tesla, Inc. (TSLA) : Free Stock Analysis Report
UiPath, Inc. (PATH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.